(2018). Risedronate as a therapeutic trial post-hysterectomy in premenopausal women to prevent osteoporosis. , 14(1), 8-12.
. "Risedronate as a therapeutic trial post-hysterectomy in premenopausal women to prevent osteoporosis". , 14, 1, 2018, 8-12.
(2018). 'Risedronate as a therapeutic trial post-hysterectomy in premenopausal women to prevent osteoporosis', , 14(1), pp. 8-12.
Risedronate as a therapeutic trial post-hysterectomy in premenopausal women to prevent osteoporosis. , 2018; 14(1): 8-12.


Journal Management System. Powered by iJournalPro.com